Brochures

PBMC Network

  • September 30, 2016

Using peripheral blood mononuclear cells (PBMC) for cell-based immunological assays is a powerful tool to understand and characterize immune mechanisms related to immunotherapies. To address this critical need, ABL has developed a network of international laboratories for timely and high quality PBMC processing & storage using harmonized SOPs and training.

Download

Lymphoproliferation by CFSE

  • July 14, 2016

Lymphoproliferation is one of the classic assessments of lymphocyte response to in vitro stimulation.

Download

Macrophage-Specific Tumor Cell Immunophenotyping

  • July 14, 2016

Flow cytometric analysis of tumor-associated macrophages is performed by our scientists through the use of cell-specific antibodies plus positive and negative magnetic bead-based cell isolation.

Download

MSD Assay Development and Sample Analysis

  • July 14, 2016

We offer an array of MSD-based immunoassays with a proven increase in both dynamic range and sensitivity, made possible through electrochemiluminescent labeling.

Download

AUSHON Immunoassays

  • July 14, 2016

Ultrasensitive biomarker detection combined with multiplexing

Download

Luminex xMAP Technology as an Alternative to ELISA

  • July 14, 2016

The Luminex xMAP technology offers significant advantages over traditional bioassays by offering high-throughput multiplexing of up to 100 analytes in a single well of a microtiter plate.

Download

GMP Vaccine & Viral Vector Production

  • April 27, 2016

ABL has an exceptional history in the development and production of preclinical and clinical viral-based biologics. From 30 years of groundbreaking work with HIV to supporting the latest gene therapy technologies, ABL offers a comprehensive portfolio of services for the effective design, development, production and testing of vaccine and gene therapy candidates.

Download

Protein Manufacturing Brochure

  • April 27, 2016

ABL’s expertise with protein-based therapies began with the discovery of IL-2 and has spanned over 25 years of cGMP manufacturing for industry and government clients. In addition to providing comprehensive process development and manufacturing services for microbial and mammalian processes, ABL offers in vivo and in vitro preclinical testing for optimal integration of discovery, preclinical and clinical activities.

Download

Government Partnering Brochure

  • April 25, 2016

ABL was established over 50 years ago as a government contractor. We are currently managing hundreds of millions of dollars in contracts in the biotechnology and biomedical fields. Together we can create winning product development solutions.

Download

Contract Research Brochure

  • April 21, 2016

ABL has over 50 years of experience partnering with clients to meet their preclinical drug development goals. We provide services to clients with the goal of advancing their protein therapeutics, vaccines, peptides, microbicides, and small molecules into the clinic. We provide a full range of research services, integrating in vivo and in vitro capabilities, for efficient candidate development.

Download

Immunobiology Brochure

  • April 21, 2016

Revolutionary treatments require innovative analytics. ABL’s immunologists have decades of experience developing immunoassays for challenging vaccine and therapeutic products in oncology, autoimmune disorders, and HIV and other infectious disease indications.

Download